Challenges in Achieving Adequate Vitamin D Status in the Adult Population/ Part 2
NCT ID: NCT03810261
Last Updated: 2021-06-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
105 participants
INTERVENTIONAL
2019-01-08
2019-04-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A randomised controlled intervention trial will be conducted on at least 72 subjects (18-65 years) with suboptimal Vitamin D status. Subjects will be selected from a pool of subjects in Part 1 of the study, after completion of winter sampling.
Study subjects will be randomised into four study groups (at least 18 subjects per study group). Three different treatments will be compared with a control group, which will not receive any supplemental Vitamin D. The three tested Vitamin D preparations in the treatment groups will be (A) oil-based VALENS vitamin D; (B) water-based VALENS vitamin D; and (C) Vitamin D capsules with starch-adsorbed vitamin D (powder). All these products are commercially available. Prior to study, actual level of vitamin D will be determined using appropriate analytical method. The treatment will be with 1000 IU Vitamin D per day, for two months, in all three groups. Second serum vitamin D level will be determined on last day of the treatment, and compared with pre-treatment vitamin D level.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Challenges in Achieving Adequate Vitamin D Status in the Adult Population - Part 1
NCT03818594
Challenges in Achieving Adequate Vitamin D Status in the Adult Population - Part 3 (VITAD/3)
NCT05641818
Effects of Different Vitamin D3 Formulations in Vitamin D-Deficient Adults
NCT07317830
High-dose Vitamin D Supplements in Older Adults
NCT03613116
The Efficacy of Different Vitamin D Supplementation Delivery Methods
NCT03463642
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oil-based vitamin D group
Oil-based vitamin D, 1000 IU/day for 8 weeks
Oil-based vitamin D
Participants will receive oil-based VALENS vitamin D, 1000 IU/day for 8 weeks.
Water-based vitamin D group
Water-based vitamin D, 1000 IU/day for 8 weeks
Water-based vitamin D
Participants will receive water-based VALENS vitamin D, 1000 IU/day for 8 weeks.
Vitamin D capsules group
Vitamin D capsules with starch-adsorbed vitamin D (powder), 1000 IU/day for 8 weeks
Vitamin D capsules
Participants will receive vitamin D capsules with starch-adsorbed vitamin D (powder), 1000 IU/day for 8 weeks.
Control group
This group will receive no intervention.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oil-based vitamin D
Participants will receive oil-based VALENS vitamin D, 1000 IU/day for 8 weeks.
Water-based vitamin D
Participants will receive water-based VALENS vitamin D, 1000 IU/day for 8 weeks.
Vitamin D capsules
Participants will receive vitamin D capsules with starch-adsorbed vitamin D (powder), 1000 IU/day for 8 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Signed Informed consent form (ICF),
* Caucasian race
* Age between 18 and 65 years at the time of the signature of Informed consent form (ICF),
* Willingness to avoid a consumption of any food supplements containing Vitamin D during the study, except the ones prescribed by the study researchers, and to avoid use of solarium or other artificial UVB sources
* Willingness to follow all study procedures
Exclusion Criteria
* Known or suspected allergy to any ingredient of the tested products in Part 2,
* Pronounced avoidance of sunshine (eg reporting of allergy to the sun)
* Use of food supplements containing Vitamin D or fish oil or omega 3 fatty acids in last three months prior to inclusion,
* Special dietary habits used by a small part of the population (veganism, low-carb high-fat (LCHF) diet, caloric restriction diet, note: vegetarians are not excluded)
* Diets prescribed by the medical profession
* Disorders of the kidneys, thyroid, digestive tract, osteoporosis and other bone diseases, skin diseases
* Other diseases and conditions that affect the absorption and synthesis of vitamin D
* Exposure to stronger sunlight in the last three months prior to engaging in a survey (travel to countries with stronger sunshine, use of solarium),
* The consumption of margarine or plant substitutes for milk / milk products several times a day, as these foods are most often enriched with vitamin D,
* Visiting the solarium in the last three months before joining the survey,
* Mental incapacity that precludes adequate understanding or cooperation.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VIST - Faculty of Applied Sciences
OTHER
Slovenian Research Agency
OTHER
Valens Int. d.o.o., Slovenija
INDUSTRY
Institute of Nutrition, Slovenia (Nutris)
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Katja Žmitek, PhD
Role: PRINCIPAL_INVESTIGATOR
Researcher
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nutrition Institute, Ljubljana
Ljubljana, , Slovenia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VITAD-01-2018 Part 2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.